Faculty of Health & Social Sciences, Bournemouth University, Dorset, UK
It is well-established that for a considerable period the United Kingdom has spent proportionally less of its gross domestic product (GDP) on health-related services than almost any other comparable country. Average European spending on health (as a % of GDP) in the period 1980 to 2013 has been 19% higher than the United Kingdom, indicating that comparable countries give far greater fiscal priority to its health services, irrespective of its actual fiscal value or configuration. While the UK National Health Service (NHS) is a comparatively lean healthcare system, it is often regarded to be at a ‘crisis’ point on account of low levels of funding. Indeed, many state that currently the NHS has a sizeable funding gap, in part due to its recently reduced GDP devoted to health but mainly the challenges around increases in longevity, expectation and new medical costs. The right level of health funding is a political value judgement. As the data in this paper outline, if the UK ‘afforded’ the same proportional level of funding as the mean averageEuropean country, total expenditure would currently increase by one-fifth.
Mladovsky P, McKee M, Ingleby D, Rechel B. Greater public investment is needed to fund the NHS at a level considered normal in other high income countries. LSE Health and Social Care, London School of Economics; 2016.
Ingleby D, McKee M, Mladovsky P, Rechel B. How the NHS measures up to other health systems. BMJ. 2012;344:e1079. doi:10.1136/bmj.e1079
Roberts A, Thompson S, Charlesworth A, Gershlick B, Stirling A. Filling the Gap: Tax and Fiscal Options for a Sustainable UK Health and Social Care System. London: The Health Foundation; 2015.
Faden RR, Chalkidou K, Appleby J, Walters HR, Leider J. Expensive cancer drugs: A comparison between the United States and the United Kingdom. Milbank Q. 2009;87:789-819. doi:10.1111/j.1468-0009.2009.00579.x
Department of Health. Improving Outcomes: A Strategy for Cancer. London: Department of Health; 2011.
Jonsson L, Justo NM, Krinshna A, et al. Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study. Eur J Cancer Care (Engl). 2015;25(3):466-477. doi:10.1111/ecc.12322
Pritchard C, Hickish T, Rosenorn-Lanng E, Wallace M. Comparing UK and 20 Western countries’ efficiency in reducing adult (55–74) cancer and total mortality rates 1989–2010: Cause for cautious celebration? A population-based study. JRSM Open. 2016; Forthcoming. doi:10.1177/2054270416635036
Francis R. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. London: The Stationary Office; 2013.
Gershlik B, Charlesworth A, Taylor A. Public Attitudes to the NHS: An analysis of responses to questions in the British Social Attitudes Survey. London: The Health Foundation and National Centre for Social Research; 2015.
Harding AJE, Sanders F, Medina Lara A, et al. Patient Choice for Older People in English NHS Primary Care: Theory and Practice. ISRN Fam Med. 2014;2014: 742676. doi:10.1155/2014/742676
Bambra C, Fox D, Scott-Samuel A. Towards a politics of health. Health Promot Int. 2005;20(2):187-193. doi:10.1093/heapro/dah608
Pritchard C, Hickish T. Comparing cancer mortality rates in England & Wales with other major developed countries 1979-2006. Br J Cancer. 2011;105(11):1788-1794. doi:10.1038/bjc.2011.393
Pritchard C, Wallace MS. Comparing the USA, UK and 17 Western countries’ efficiency and effectiveness in reducing mortality. JRSM Short Rep. 2011;2(7):60. doi:10.1258/shorts.2011.011076
Pritchard C, Wallace MS. Comparing UK and other Westerns countries’ health expenditure, relative poverty & child mortality. Are British children doubly disadvantaged? Child Soc. 2015;29(5):462-472. doi:10:111/chso.12079